Abstract A051: Spatial features of the tumor microenvironment predict recurrence risk in resected pancreatic ductal adenocarcinoma after total neoadjuvant therapy

Abstract Introduction Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers. While total neoadjuvant therapy (TNT) has improved outcomes, recurrence rates remain high. Major pathologic response after TNT is prognostic of better survival, but is rarely achieved. Current pathologic systems primarily consider residual tumor percentage, nodal status, and perineural invasion but overlook spatial organization within the tumor microenvironment (TME). We aimed to evaluate spatial features of the TME to identify biologically and clinically relevant patterns of TME conformation and configuration after TNT and surgical resection of PDAC. Methods We retrospectively analyzed patients with PDAC treated with TNT followed by surgery at Mayo Clinic (2010-2022) with partial or no response per College of American Pathologists (CAP) criteria. Hematoxylin and eosin-stained whole slide images (WSIs) were processed using PathExplore™ PDAC (v1. 0) to quantify spatial TME features. These were correlated with disease-free survival (DFS). Results A total of 203 patients were included: 47. 3% female, median age 66. 5 years. All received TNT; 73. 4% had neoadjuvant chemotherapy followed by chemoradiation. Surgical procedures included pancreaticoduodenectomy (62. 1%), distal pancreatectomy (22. 2%), and total pancreatectomy (15. 8%). CAP-defined response was partial in 82. 1% and absent in 17. 9%. As expected, pathologic T stage (p=0. 001), N stage (p=0. 002), lymphovascular invasion (p=0. 048), and R2 resection (p=0. 007) were significantly associated with DFS. However, CAP response category (p=0. 053), residual cancer area (p=0. 47), and cancer-to-stroma ratio (p=0. 25) were not. We analyzed 297 WSIs from 203 patients. Of 31 spatial features evaluated, 5 were associated with DFS (p0. 20). Recursive partitioning using ln (mean cancer shape index CSI) 1. 775 and ln (SD of stroma shape index SSI) 0. 651 identified a high-risk group (n=63) with median DFS of 7. 23 months (95% CI: 5. 19–9. 63), compared to 11. 57 months in the low-risk group (95% CI: 9. 24–17. 92) (HR=1. 82; 95% CI: 1. 31–2. 52; p=0. 0003). This remained significant after adjusting for T and N stage (HR=1. 75; 95% CI: 1. 17–2. 63; p=0. 007). An alternate prognostic index derived via backwards elimination, calculated using 0. 2701 (mean stromal area) + 0. 3905 (edge density), also stratified patients. High-risk patients (n=51) had a significantly shorter (p0. 001) DFS (6. 2 months) than those in the low-risk category (20. 0 months). This significant difference holds in a multivariable analysis controlling for pathologic stage, N stage, and resection margins (HR=1. 94, 95% CI: 1. 21-3. 10, p=0. 006). Discussion Current assessment of residual PDAC after TNT is limited by subjective grading and lack of spatial context. Using Tumor Landscape Analysis, we identified high-risk spatial features of the TME that independently predict recurrence. These findings support a novel spatially-informed framework for risk stratification in resected PDAC with residual disease. Citation Format: Miranda Lin, Luis Cisneros, Merih D. Toruner, Andrea Maraone, Paul Dizona, Qian Shi, Martin E. Fernandez-Zapico, Ryan M. Carr. Spatial features of the tumor microenvironment predict recurrence risk in resected pancreatic ductal adenocarcinoma after total neoadjuvant therapy abstract. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research—Emerging Science Driving Transformative Solutions; Boston, MA; 2025 Sep 28-Oct 1; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2025;85 (18Suppl₃): Abstract nr A051.